Turtle Creek Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.5M Buy
22,513
+2,578
+13% +$600K 0.42% 63
2025
Q4
$4.13M Buy
19,935
+1,908
+11% +$377K 0.32% 75
2025
Q3
$3.34M Buy
18,027
+10,013
+125% +$1.72M 0.3% 79
2025
Q2
$1.22M Buy
+8,014
New +$1.23M 0.14% 107
2024
Q4
Sell
-5,588
Closed -$906K 121
2024
Q3
$906K Buy
5,588
+372
+7% +$59.3K 0.18% 77
2024
Q2
$762K Buy
5,216
+1,076
+26% +$160K 0.18% 74
2024
Q1
$655K Buy
4,140
+1,394
+51% +$222K 0.16% 82
2023
Q4
$430K Buy
+2,746
New +$421K 0.13% 97

Other funds holding JNJ

Turtle Creek Wealth Advisors's JNJ Position: Q1 2026 in Review

Turtle Creek Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 13% in Q1 2026, buying an estimated $600K and bringing the position to 22,513 shares worth $5.5M. The position accounts for 0.42% of the portfolio, ranked #63.

Turtle Creek Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 8 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Turtle Creek Wealth Advisors held 22,513 shares of Johnson & Johnson worth $5.5M as of Q1 2026.
  • Turtle Creek Wealth Advisors bought 2,578 Johnson & Johnson shares in Q1 2026, an estimated $600K.
  • Johnson & Johnson made up 0.42% of Turtle Creek Wealth Advisors's portfolio in Q1 2026, its #63 holding.
  • Turtle Creek Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 8 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.